Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00835731 · ClinicalTrials.gov registry record · NA
Misoprostol Versus Dilapan-S for Cervical Preparation
A NA study, sponsored by Planned Parenthood League of Massachusetts.
- Completed
- Registry status
- NA
- Development phase
- 125
- Enrollment target
NCT00835731 is a NA study that has completed, run by Planned Parenthood League of Massachusetts. The registered enrollment target is 125 participants.
The verdict
NCT00835731, a NA study, has completed, sponsored by Planned Parenthood League of Massachusetts.
- COMPLETED
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the dilatory effect of 400 mcg of buccally administered misoprostol to one Dilapan-S rod placed 3-4 hours before abortion by dilation and evacuation in women who are 12 weeks 0 days to 15 weeks 0 days gestation.
Interventions
- DRUG misoprostol
- DEVICE Dilapan-S, vitamin B-12
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2009-01 |
| Est. Completion | 2011-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00835731
The ClinicalTrials.gov registry entry for NCT00835731 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Planned Parenthood League of Massachusetts, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which misoprostol is the first listed.
NCT00835731 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00835731 about?
NCT00835731 is a clinical study titled "Misoprostol Versus Dilapan-S for Cervical Preparation". The purpose of this study is to compare the dilatory effect of 400 mcg of buccally administered misoprostol to one Dilapan-S rod placed 3-4 hours before abortion by dilation and evacuation in women who are 12 weeks 0 days to 15 weeks 0 days gestation.
What is the current status of trial NCT00835731?
This trial is currently completed. It is a NA study. The enrollment target is 125 participants. The study started on 2009-01. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00835731?
The interventions under investigation include: misoprostol (DRUG), Dilapan-S, vitamin B-12 (DEVICE).
Who is sponsoring clinical trial NCT00835731?
This trial is sponsored by Planned Parenthood League of Massachusetts, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.